COLD STORAGE 2–8 °C
A 2–8 °C requirement needs a complete cold-chain process. Before any storage commitment, the product specification, suitable available zone, temperature mapping, monitoring, emergency procedures and refrigerated transport handover are assessed together.
AT A GLANCE
Pharmaceutical cold storage requires a suitable and qualified refrigerated zone, continuous temperature monitoring, alarms and documented excursion and handover procedures. Explore pharmaceutical warehousing for Germany →
The approved product information determines whether 2–8 °C storage is required. Volumes, packaging, stock movements and start date determine whether a suitable zone can support the project. The total warehouse pallet capacity is not a promise of refrigerated capacity for every medicine or volume.
A cold-storage process requires evidence of suitable temperature distribution, calibrated measurement equipment, monitoring and defined alarm responses. Maintenance, training, emergency arrangements and excursion handling are part of the assessment. Room qualification and operational use need to match.
Arrival condition, timing, temperature records and product status are checked under the agreed procedure. Goods with unresolved issues remain blocked pending a responsible decision. Picking, staging and handover to a suitable carrier must continue the confirmed temperature process.
Affected stock is identified and controlled. The duration and extent of the excursion, sensor records, product limits and available stability information inform the assessment. An alarm does not itself authorise release or rejection; the responsible function determines the next stock status.
Send the product group, approved storage condition, pallet or container volumes, arrival and dispatch frequency, packaging, permitted handling times, destination market and planned start. These details support a technical assessment and quotation rather than an unqualified capacity claim.
STORAGE CONDITIONS
These ranges describe requirements to assess. Product information and confirmed zone suitability determine availability for an individual project.
| Temperature | Product requirement | Controls to assess |
|---|---|---|
| 2–8 °C | Refrigerated medicines where required by the approved product information | Project-confirmed cold room, temperature mapping, continuous monitoring, alarms and a defined cold-chain handover |
| 15–25 °C | Controlled room temperature where specified for the product | Suitable storage zone, temperature mapping, calibrated sensors, monitoring and excursion assessment |
| Product-specific | Narrower or different storage limits | Individual assessment of product requirements, stability information, packaging and the complete handling process |
FREQUENTLY ASKED QUESTIONS
No blanket capacity commitment is made. Availability and suitability are checked for the product, volume, handling profile and start date.
Typical evidence includes zone qualification and mapping, calibrated sensors, monitoring records, alarm tests, maintenance, training and documented excursion and emergency procedures.
Affected goods are identified and blocked while duration, extent, measurement data and product requirements are assessed by the responsible function.
Yes. Product, route, packaging or vehicle concept, monitoring and qualified-carrier availability are evaluated as part of the project.
REGULATORY BASIS
The process descriptions refer to the EU Guidelines on Good Distribution Practice of medicinal products for human use (2013/C 343/01). Site, legal entity and authorised activity scope must be verified before project start through the competent authority and relevant EudraGMDP records. SÚKL is the national medicines authority for Czech sites.
English content updated: 11 October 2026 · Pharmaceutical contact: Martin Didunyk, licensed pharmacist.
RELATED SERVICES